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Abstract: Treatment of 7-(2,3,5-tris-Q-(t-butyldimethylsilyl)-R~-~~f~osyl)i~dazo[4,5-~-v-~az~-4-one 
(1) with Mn@ in hot pyridine furnished 7-(2,3,5-tris-Q-(t-butyldimethylsilyl)-0do[ 1,2-a]- 
purine (4). Treatment of 4 with tetra-a-butylammonium fluoride furnished the free nucleoside 5. 
Tricyclic nucleosides are of current interestI- not only for their biological activity, but also because many 
tricyclic nucleosides are fluorescent, and can serve as useful probes of biological processes. Additionally, several 
imidazo[ 1,2-glpurines (“Y” bases) have been found to occur in tRNA from several sources,4.5 and pyrimido- 
[ 1,2-dpurines are though6 to be formed by the action of certain mutagens on the guanine bearing bases of DNA 
and RNA. This report describes the isolation and characterization of a novel pyrido[ 1,2-dpurine nucleoside. 
During our attempts7 to prepare 4-amino-7-(l3-Q-ribofuranosyl)imidazo[4,5-&Wriazine (2-azaadenosine) 
from 7-(2,3,5-tris-Q-(t-butyldimethylsilyl)-R-Q-~bofuranosyl)imidazo[4,5-~-_v-triazin-4-one (l), we observed 
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the m-acetate of inosine with phosphorous oxychloride in pyridine had been reported8 to furnish the 4-pyridinium 
salt 2, and air oxidation of 2 provided the fluorescent tricyclic betaine nucleoside 3. However, upon isolation, de- 
blocking and characterization, our fluorescent product (4) was found to be different from the previously described 
betaine 3. In order to fully characterize this product, the silyl protecting groups were removed with tetra-p- 
butylammonium fluoride to obtain the deprotected nucleoside. This nucleoside was examined by IH NMR, 13 C 
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NMR, IR, mass spectroscopy, and elemental analysis which allowed us to assign the structure of 3-03-P 
ribofuranosyl)pyrido[ 1,2-a]purin-lo-one (5) to our fluorescent nucleoside. To the best of our knowledge, this 
novel ring system has not been reported previously. 
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Our structural assignment for 5 was based on the observation of four new peaks in the aromatic region of 
the proton NMR spectrum which through analysis of the coupling patterns were assigned to lie contiguously on an 
aromatic ring. The most de-shielded proton in the IH NMR spectrum was assigned to the C-8 position. The 
proximity of this proton to a carbonyl moiety was consistent with the observation of a three-bond coupling of this 
proton with a carbon atom having the furthest downfield absorbtion in the 1% spectrum, which in turn was 
assigned as the carbonyl carbon, C- 10. The other three-bond proton-carbon couplings in the l3C spectrum were 
consistent with the assigned structure, as were the proton-proton coupling patterns. Several mechanisms for the 
formation of this compound were considered. The one chosen to be the most likely involved a nucleophilic attack 
by the pyridine nitrogen lone pair at the carbonyl group of 1, with a concomitant cleavage of the triazine ring 
between N-3 and C-4 to form a charged pyridinium moiety as well as a triazene moiety. Following the expulsion 
of molecular nitrogen from the newly formed triazene moiety, the attack of the nascent amino group on the 
pyridinium group would form a dihydro intermediate which could be air oxidized to afford the product. Indeed, 
heating 1 in pytidine at reflux, in the presence or absence of phosphorous oxychloride only afforded traces of 4, 
while the reaction in the presence of manganese dioxide afforded 4 in a much improved yield These results 
suggested that an oxidation step is involved in the reaction mechanism and that the presence of phosphorous 
oxychloride is superfluous. 
Ring cleavage of the triazine ring of 3-(l3-l&ibofuranosyl)imidazo[4,5-P]-~-triazin-4-one has been 
reported10 to occur upon treatment of the nucleoside with Raney nickel. However, in this case, the cleavage 
occurred at the 2,3-bond and not at the 3,4-bond as we propose here. The most closely related reaction, of which 
we are aware, is the formation of y-triazolo[4,5$Jpyridines from the treatment of y-triazolo[4,5-&lpyrimidines 
with malononitrile and or other reagents containing strongly activated methylene groups.11 In this latter case, the 
reaction takes place with a fission of the pyrimidine ring and the subsequent annulation of the freed amino group 
with the attacking reagent. This is reminiscent of the mechanism which we have set forth here. To examine the 
scope of this reaction, 1 was heated in toluene at reflux with manganese dioxide and imidazole, but TLC analysis 
of this reaction did not identify any significant formation of products. In contrast, when 1 was mixed with 
imidazole and the mixture was heated tom. 130°, evolution of a gas was noted, and the imidazoylcarbonyl- 
imidazole 6 was formed in good yield9 (Scheme 2). Evidently ring closure was not favored when there is no 
positive charge formed on the attacking heterocycle. Preliminary experiments using 1,2,4-triazole instead of 
imidazole in this reaction would suggest that the formation of a corresponding triazoylcarbonylimidazole 
nucleoside is also possible, and we are exploring the applicability of this reaction to the synthesis of a variety of 
fused tricyclic nucleosides. 
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